Condor Capital Management’s PepperLime Health Acquisition Corporation Unit PEPLU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-5,990
Closed -$60K 497
2022
Q3
$60K Hold
5,990
0.01% 272
2022
Q2
$59K Sell
5,990
-1,160
-16% -$11.6K 0.01% 265
2022
Q1
$72K Sell
7,150
-1,000
-12% -$10.2K 0.01% 245
2021
Q4
$80K Buy
+8,150
New +$81.4K 0.01% 217

Other funds holding PEPLU

Condor Capital Management's PEPLU Position: Q4 2022 in Review

Condor Capital Management sold out of PepperLime Health Acquisition Corporation Unit (PEPLU) in Q4 2022, closing a stake of 5,990 shares — an estimated $60K sold.

Condor Capital Management first reported a position in PEPLU in Q4 2021 and held it in 4 quarters. The position peaked at $80K in Q4 2021. 6 funds tracked by Wall St. Rank hold PEPLU as of Q4 2022.

  • Condor Capital Management reported no remaining PepperLime Health Acquisition Corporation Unit position as of Q4 2022 after selling out during the quarter.
  • Condor Capital Management sold 5,990 PepperLime Health Acquisition Corporation Unit shares in Q4 2022, an estimated $60K.
  • Condor Capital Management first reported a position in PepperLime Health Acquisition Corporation Unit in Q4 2021 and held it in 4 quarters.
  • Condor Capital Management's PepperLime Health Acquisition Corporation Unit position peaked at $80K in Q4 2021.
  • 6 funds tracked by Wall St. Rank held PepperLime Health Acquisition Corporation Unit as of Q4 2022.

Based on Condor Capital Management's 13F filing for Q4 2022, filed 7 Feb 2023.